FindTrial
Sign In

Clinical Research on the Effects of Gengnianningxin Granules to Treat Climacteric Syndrome

Clinical Research on the Effects of Gengnianningxin Granules to Treat Climacteric Syndrome

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-14005098
Enrollment
Unknown
Registered
2014-07-10
Start date
2014-01-06
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perimenopausal syndrome

Interventions

Experimental group:Gengnianningxin granule
control group:Placebo

Sponsors

Longhua hospital Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
40 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. female,40-60 years old; 2. FSH more than at least 15IU/L; 3. Improved Kupperman's score more than 15 points; 4. Accord with the diagnostic criteria; 5. Sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. With severe physical illness such as heart, liver, kidney, brain and serious body disease and malignant tumor; 2. Menstrual disorder more than 6 months; 3. Diagnosed with thyroid disease; 4. Allergic to known drug ingredients; 5. Bilateral ovaries removed; 6. Recently 3 months use sex hormone drugs, or participate in other clinical trials; 7. Disagree with the informed consent.

Design outcomes

Primary

MeasureTime frame
FSH;LH;Improved Kupperman score;—

Secondary

MeasureTime frame
Blood routine;urine routine;estradiol;ECG;Uterine accessories ultrasound;—

Countries

China

Contacts

Public ContactLi Ji
josephlee@sh163.net+86 18917763030

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026